BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11505080)

  • 1. Low molecular weight heparin prevents activation of coagulation in a hypobaric environment.
    Bendz B; Sevre K; Andersen TO; Sandset PM
    Blood Coagul Fibrinolysis; 2001 Jul; 12(5):371-4. PubMed ID: 11505080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between acute hypoxia and activation of coagulation in human beings.
    Crosby A; Talbot NP; Harrison P; Keeling D; Robbins PA
    Lancet; 2003 Jun; 361(9376):2207-8. PubMed ID: 12842377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
    Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
    Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation.
    Toff WD; Jones CI; Ford I; Pearse RJ; Watson HG; Watt SJ; Ross JA; Gradwell DP; Batchelor AJ; Abrams KR; Meijers JC; Goodall AH; Greaves M
    JAMA; 2006 May; 295(19):2251-61. PubMed ID: 16705106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluid loss does not explain coagulation activation during air travel.
    Schreijer AJ; Cannegieter SC; Caramella M; Meijers JC; Krediet RT; Simons RM; Rosendaal FR
    Thromb Haemost; 2008 Jun; 99(6):1053-9. PubMed ID: 18521508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin, a low-molecular-weight heparin suppresses prothrombin activation more effectively than unfractionated heparin in patients treated for venous thromboembolism.
    Grosset AB; Spiro TE; Beynon J; Rodgers GM
    Thromb Res; 1997 Jun; 86(5):349-54. PubMed ID: 9211625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between acute hypobaric hypoxia and activation of coagulation in human beings.
    Bendz B; Rostrup M; Sevre K; Andersen TO; Sandset PM
    Lancet; 2000 Nov; 356(9242):1657-8. PubMed ID: 11089830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
    Raaz U; Kaeberich A; Maegdefessel L; Buerke M; Busshardt M; Schubert S; Russ M; Plehn A; Ebelt H; Werdan K; Schlitt A
    Thromb Haemost; 2010 Apr; 103(4):808-14. PubMed ID: 20174756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor.
    Bara L; Bloch MF; Zitoun D; Samama M; Collignon F; Frydman A; Uzan A; Bouthier J
    Thromb Res; 1993 Mar; 69(5):443-52. PubMed ID: 8388583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
    Bombeli T; Raddatz Mueller P; Fehr J
    Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.